Phenotypic characterization of drug resistance and tumor initiating cancer stem cells from human bone tumor osteosarcoma cell line OS-77

被引:1
|
作者
Zhang, Yue [1 ]
Quan, Ren-Fu [2 ]
Chen, Wei-Shan [1 ]
Ye, Zhao-Ming [1 ]
Li, Wei-Xu [1 ]
Yang, Di-Sheng [1 ]
机构
[1] Zhejiang Univ, Affiliated Hosp 2, Dept Orthopaed, Hangzhou 310052, Zhejiang, Peoples R China
[2] Zhejiang Univ, Xiaoshan Tradit Chinese Med Hosp, Dept Orthopaed, Hangzhou 311201, Zhejiang, Peoples R China
基金
中国国家自然科学基金;
关键词
Anticancer drug; Cancer stem cell; Drug resistance; Metastasis; IDENTIFICATION; OCT4;
D O I
10.3329/bjp.v9i3.19891
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The cancer stem cell theory suggest that presence of small subpopulation of cancer stem cells are the major implication in the cancer treatment and also responsible for tumor recurrence. Based on Hoechst 33342 dye exclusion technique, we have identified about 3.3% of cancer stem like side population (SP) cells from human osteosarcoma OS-77 cell line whose prevalence is significantly reduced to 0.3% after treatment with verapamil. The sphere formation assay revealed that osteosarcoma SP cells are highly capable to form tumor spheres (sarcospheres). Further by immunocytochemistry and RT-PCR, we show that OS-77 SP cells have enhanced expression of stem cell surface markers such as CD44, Nanog and ATP-binding cassette (ABC) transporter gene (ABCG2) which contributes to self-renewal and drug resistance, respectively. Our findings help to designing a novel therapeutic drug which could effectively target the cancer stem cells and prevent the tumor relapse.
引用
收藏
页码:437 / 442
页数:6
相关论文
共 50 条
  • [31] Phenotypic Characterization of Circulating Tumor Cells Isolated from Non-Small and Small Cell Lung Cancer Patients
    Roumeliotou, Argyro
    Pantazaka, Evangelia
    Xagara, Anastasia
    Dimitrakopoulos, Foteinos-Ioannis
    Koutras, Angelos
    Christopoulou, Athina
    Kourelis, Theodoros
    Aljarba, Nada H.
    Alkahtani, Saad
    Koinis, Filippos
    Kotsakis, Athanasios
    Kallergi, Galatea
    CANCERS, 2023, 15 (01)
  • [32] Impact of Cancer Stem Cells and Cancer Stem Cell-Driven Drug Resiliency in Lung Tumor: Options in Sight
    Cortes-Dericks, Lourdes
    Galetta, Domenico
    CANCERS, 2022, 14 (02)
  • [33] Interleukin-12 inhibits the survival of human colon cancer stem cells in vitro and their tumor initiating capacity in mice
    Yin, Xiao-ling
    Wang, Ning
    Wei, Xing
    Xie, Gan-feng
    Li, Jian-jun
    Liang, Hou-jie
    CANCER LETTERS, 2012, 322 (01) : 92 - 97
  • [34] Combined gemcitabine and CHK1 inhibitor treatment induces apoptosis resistance in cancer stem cell-like cells enriched with tumor spheroids from a non-small cell lung cancer cell line
    Douglas D. Fang
    Joan Cao
    Jitesh P. Jani
    Konstantinos Tsaparikos
    Alessandra Blasina
    Jill Kornmann
    Maruja E. Lira
    Jianying Wang
    Zuzana Jirout
    Justin Bingham
    Zhou Zhu
    Yin Gu
    Gerrit Los
    Zdenek Hostomsky
    Todd VanArsdale
    Frontiers of Medicine, 2013, 7 : 462 - 476
  • [35] A side population of cells from a human pancreatic carcinoma cell line harbors cancer stem cell characteristics
    Wang, Y. H.
    Li, F.
    Luo, B.
    Wang, X. H.
    Sun, H. C.
    Liu, S.
    Cui, Y. Q.
    Xu, X. X.
    NEOPLASMA, 2009, 56 (05) : 371 - 378
  • [36] A tumor hypoxic niche protects human colon cancer stem cells from chemotherapy
    Mao, Qin
    Zhang, Yu
    Fu, Xiaoyue
    Xue, Jianxin
    Guo, Wenhao
    Meng, Maobing
    Zhou, Zongguang
    Mo, Xianming
    Lu, You
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2013, 139 (02) : 211 - 222
  • [37] Phenotypic characterization of mammosphere-forming cells from the human MA-11 breast carcinoma cell line
    Rappa, Germana
    Lorico, Aurelio
    EXPERIMENTAL CELL RESEARCH, 2010, 316 (09) : 1576 - 1586
  • [38] Exosome secretion from hypoxic cancer cells reshapes the tumor microenvironment and mediates drug resistance
    To, Kenneth K. W.
    Cho, William C. S.
    CANCER DRUG RESISTANCE, 2022, 5 (03) : 577 - 594
  • [39] Cancer cell plasticity: from cellular, molecular, and genetic mechanisms to tumor heterogeneity and drug resistance
    Gh Rasool Bhat
    Itty Sethi
    Hana Q. Sadida
    Bilal Rah
    Rashid Mir
    Naseh Algehainy
    Ibrahim Altedlawi Albalawi
    Tariq Masoodi
    Gowtham Kumar Subbaraj
    Farrukh Jamal
    Mayank Singh
    Rakesh Kumar
    Muzafar A. Macha
    Shahab Uddin
    Ammira S. Al-Shabeeb Akil
    Mohammad Haris
    Ajaz A. Bhat
    Cancer and Metastasis Reviews, 2024, 43 : 197 - 228
  • [40] Tumor-Initiating Label-Retaining Cancer Cells in Human Gastrointestinal Cancers Undergo Asymmetric Cell Division
    Xin, Hong-Wu
    Hari, Danielle M.
    Mullinax, John E.
    Ambe, Chenwi M.
    Koizumi, Tomotake
    Ray, Satyajit
    Anderson, Andrew J.
    Wiegand, Gordon W.
    Garfield, Susan H.
    Thorgeirsson, Snorri S.
    Avital, Itzhak
    STEM CELLS, 2012, 30 (04) : 591 - 598